Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

28.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.1K
Gene Therapy00:59

Gene Therapy

4.8K
4.8K
What is Genetic Engineering?00:49

What is Genetic Engineering?

81.4K
Overview
81.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Bioreactor Controls-III01:22

Bioreactor Controls-III

51
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogen-generating silicon-based agent is effective in a mouse model of ovalbumin-induced allergic bronchial asthma.

Biomedical journal·2026
Same author

An Improved Brain-Penetrating Nanoformulation of the VIPR2 Antagonist Peptide KS-133 for Treating Cognitive Impairment in Schizophrenia.

Biological & pharmaceutical bulletin·2026
Same author

Combination therapy with clinically approved PPARα/δ/γ subtype-selective agonists pemafibrate, seladelpar, and pioglitazone in a 4-week diet-induced early-stage MASLD mouse model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Genetic Encoding of a Trifunctional Photo-Cross-Linker with a Cleavable Alkyl Ester Moiety.

Chembiochem : a European journal of chemical biology·2026
Same author

Neuron-specific overexpression of human vasoactive intestinal peptide receptor 2 in mice causes cognitive dysfunction and abnormal dendritic morphology in the prefrontal cortex.

Journal of pharmacological sciences·2026
Same author

Discovery of a Selective Inhibitor of ZIP14 with Therapeutic Potential for Cancer-associated Cachexia.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Apr 3, 2026

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

1.1K

[DDS Research Aimed at Optimizing Gene and Cell Therapies].

Shinsaku Nakagawa1

  • 1Graduate School of Pharmaceutical Sciences, The University of Osaka.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|April 1, 2026
PubMed
Summary

This study optimized gene therapy vectors for cancer treatment. Polyethylene glycol-conjugated adenovirus vectors (PEG-Ad) with specific peptides improved tumor targeting and reduced liver accumulation, enhancing therapeutic efficacy against metastatic tumors.

Keywords:
adenovirus vectorcytokinedrug delivery system (DDS)gene therapypolyethylene glycol (PEG)

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.5K
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

12.1K

Related Experiment Videos

Last Updated: Apr 3, 2026

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

1.1K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.5K
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

12.1K

Area of Science:

  • Biomedical Engineering
  • Gene Therapy
  • Immunotherapy

Background:

  • Optimizing drug delivery systems (DDS) is crucial for effective gene and cell therapies.
  • Adenovirus vectors are promising for gene therapy but require improved targeting and reduced off-target effects.
  • Controlling in vivo immune cell dynamics is key to enhancing tumor immunotherapy.

Purpose of the Study:

  • To develop and evaluate polyethylene glycol-conjugated adenovirus vectors (PEG-Ad) for enhanced tumor targeting and reduced liver accumulation.
  • To investigate the efficacy of a tumor-targeting peptide (CGKRK) conjugated to PEG-Ad for improved delivery to metastatic tumors.
  • To optimize tumor immunotherapy by controlling the in vivo dynamics of immune cells using cytokines and chemokines.

Main Methods:

  • Conjugation of polyethylene glycol (PEG) to adenovirus vectors (Ad) to create PEG-Ad, with varying PEGylation rates (e.g., 90%).
  • Attachment of a tumor-targeting peptide, Cys-Gly-Lys-Arg-Lys (CGKRK), to PEG-Ad to create CGKRK-PEG-Ad.
  • Intratumoral administration of modified adenovirus vectors carrying cytokines (e.g., interleukin-12) and chemokines (e.g., CCL27) in tumor models.

Main Results:

  • A 90% PEGylation rate of Ad optimally reduced liver accumulation and enhanced tumor targeting via the enhanced permeability and retention effect.
  • CGKRK-PEG-Ad demonstrated reduced liver accumulation and superior tumor delivery compared to PEG-Ad, showing potent efficacy against metastatic tumors.
  • Combined administration of RGD-Ad-CCL27 and RGD-Ad-IL-12 significantly enhanced antitumor effects and increased the infiltration of CD3+ and perforin+ immune cells into tumors compared to RGD-Ad-IL-12 alone.

Conclusions:

  • Optimized PEGylation and peptide conjugation of adenovirus vectors significantly improve tumor targeting and therapeutic efficacy.
  • Modulating in vivo immune cell dynamics through combined chemokine and cytokine delivery enhances antitumor immunotherapy.
  • These strategies hold promise for advancing DDS in gene therapy and cancer immunotherapy.